A comprehensive clinical studies program
Our clinical research program drives discovery, development, and validation of our early cancer detection tests.
Our colorectal cancer screening study: The PREEMPT CRC® Study
The PREEMPT CRC Study is the largest clinical study validating a blood-based colorectal screening test. The PREEMPT CRC Study included more than 200 study sites across urban and rural communities, enrolling more than 40,000 participants across a range of racial, ethnic, and socioeconomic backgrounds.
We are thankful for the time and commitment of our participants and investigators to help Freenome develop tests to detect cancer early.
- Recruitment complete
Get more information on our PREEMPT CRC Study.
- Learn more at clinicaltrials.gov
Our lung cancer screening study: The PROACT LUNG Study
The PROACT LUNG Study is intended to validate the clinical performance of a blood-based test for the early detection of lung cancer. We are currently enrolling as many as 20,000 individuals who meet specific criteria.
- Recruiting
Get more information on our PROACT LUNG Study.
- Learn more at clinicaltrials.gov
Our study for multiple types of cancers: The Vallania Study
The Vallania Study is part of our commitment to expand into other cancer types with high unmet need by developing next-generation blood tests that can detect cancer in its earliest, most treatable stages. We are currently enrolling individuals aged 30 and above who meet specific criteria.
- Recruitment complete
Get more information on the Vallania Study.
- Learn more at clinicaltrials.gov